Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is classically defined by estrogen receptor (ER) and progesterone receptor (PR) immunohistochemistry expression <1% and absence of HER2 amplification/overexpression. HER2-negative breast cancer with low ER/PR expression (1–10%) has a gene expression prof...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Rachel Yoder, Bruce F. Kimler, Joshua M. Staley, Kelsey Schwensen, Yen Y. Wang, Karissa Finke, Anne O’Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Robert Pluenneke, Sheshadri Madhusudhana, Larry Beck, Anuj Shrestha, Larry Corum, Mark Marsico, Shane R. Stecklein, Andrew K. Godwin, Qamar J. Khan, Priyanka Sharma
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2022-07-01
Schriftenreihe:	npj Breast Cancer
Online-Zugang:	https://doi.org/10.1038/s41523-022-00448-4
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!